tiprankstipranks
Immunocore Holdings (IMCR)
NASDAQ:IMCR
US Market

Immunocore Holdings Financial Overview

Immunocore Holdings's market cap is currently ―. The company's EPS TTM is $-0.956; its P/E ratio is ―; Immunocore Holdings is scheduled to report earnings on February 26, 2025, and the estimated EPS forecast is $-0.23. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21Dec 20Dec 19
Income Statement
Total Revenue
Gross Profit$ 248.39M$ 143.28M$ 26.52M$ 30.11M-
Operating Income$ -60.55M$ -39.61M$ -135.10M$ -89.29M$ -118.50M
EBITDA$ -51.65M$ -30.32M-$ -75.28M$ -113.18M
Net Income$ -55.29M$ -41.22M$ -131.52M$ -74.09M$ -103.93M
Balance Sheet
Cash & Short-Term Investments$ ―$ ―$ ―$ ―$ ―
Total Assets$ 597.00M$ 435.52M$ 301.77M$ 197.19M$ 185.65M
Total Debt$ 84.03M$ 69.30M$ 63.84M$ 63.89M$ 59.41M
Net Debt$ -358.59M$ -263.24M$ -174.05M$ -65.83M$ -14.56M
Total Liabilities$ 228.16M$ 156.76M$ 130.23M$ 141.85M$ 170.88M
Stockholders' Equity$ ―$ ―$ ―$ ―$ ―
Cash Flow
Free Cash Flow$ -2.48M$ -28.08M$ -97.04M$ -64.32M$ -105.65M
Operating Cash Flow$ 2.94M$ -25.89M$ -96.11M$ -61.25M$ -101.38M
Investing Cash Flow
Financing Cash Flow
Currency in USD

Immunocore Holdings Earnings and Revenue History

Immunocore Holdings Debt to Assets

Immunocore Holdings Cash Flow

Immunocore Holdings Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis